At later stages, they found a persistent inflammatory phenotypein patients with severe COVID-19, dominated by high CCL3 and CCL4cytokine abundance correlated with the reappearance of CD16+ monocytes,while the response of mild COVID-19 patients was normalized.217. The gene discussed is CCL3; the disease is COVID-19.